OpenAlex
PricingAboutJobs
Log inGet started
Work

Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice

HTML PDF

Year: 2011
Type: article
Source: Blood
DOI: 10.1182/blood-2010-11-319137
Authors: Steffen E. Meiler, Marlene Wade, Ferdane Kutlar, Shobha D. Yerigenahally, Yongjun Xue, Laure A. Moutouh-de Parseval, Laura G. Corral, Paul S. Swerdlow, Abdullah Kutlar
Institutions: Celgene (United States), Novartis (Switzerland), Wayne State University
Language: English

Topic: Hemoglobinopathies and Related Disorders
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Keywords: pomalidomide, fetal hemoglobin induction, sickle cell disease, hydroxyurea, erythropoiesis, myelosuppression, immunomodulators, thalidomide analogues, beta-thalassemia, drug combination toxicity, bone marrow function
SDG: Good health and well-being

Open Access status: bronze

Funders: Celgene, National Institutes of Health, National Eye Institute
Award: Nanomedicine Center for Nucleoprotein Machines
OpenAlex ID: W2054016680
FWCI: 4.008
Cites: 18
Cited by: 95
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security